Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Imclone systems (IMCL) -- Ignore unavailable to you. Want to Upgrade?

To: caly who wrote (1744)	12/29/2001 2:40:35 PM
From: RCMac	Read Replies (1) \| Respond to of 2515

The Yahoo post includes this important assertion: While I can't reveal the EXACT details (less I tip my hat as to who I am), here's basically what is involved . . . In other words, "I'm an insider, bound by fiduciary obligation not to reveal this, but I'm going to tell you this anyway and conceal my identity so I don't get caught." IMO, this is either: (1) a pretty clear violation of the securities laws, if what he says about his privileged location inside is true, or (2) a lie about his position, and therefoere probably about much else. (Is there a third logical possibility?) Either way, it's untrustworthy, and a bad basis for investing, IMO. To be clear: I say this with little knowledge of the therapeutic or the company, and don't know if the dip next week will be a good buying opportunity or not (and I'm reading this thread because Friday's events raised that question for me). But I entirely discount the Yahoo post, for the reasons outlined above. My own opinion only, get your own. --RCM (sometime securities lawyer)